Display options
Cite
Nakasuka K, Ito S, Noda T, et al. Resolution of left ventricular thrombus secondary to tachycardia-induced heart failure with rivaroxaban. Case Rep Med. 2014;2014:814524doi: 10.1155/2014/814524.
Nakasuka, K., Ito, S., Noda, T., Hasuo, T., Sekimoto, S., Ohmori, H., Inomata, M., Yoshida, T., Tamai, N., Saeki, T., Suzuki, S., Murakami, Y., & Sato, K. (2014). Resolution of left ventricular thrombus secondary to tachycardia-induced heart failure with rivaroxaban. Case reports in medicine, 2014814524. https://doi.org/10.1155/2014/814524
Nakasuka, Kosuke, et al. "Resolution of left ventricular thrombus secondary to tachycardia-induced heart failure with rivaroxaban." Case reports in medicine vol. 2014 (2014): 814524. doi: https://doi.org/10.1155/2014/814524
Nakasuka K, Ito S, Noda T, Hasuo T, Sekimoto S, Ohmori H, Inomata M, Yoshida T, Tamai N, Saeki T, Suzuki S, Murakami Y, Sato K. Resolution of left ventricular thrombus secondary to tachycardia-induced heart failure with rivaroxaban. Case Rep Med. 2014;2014:814524. doi: 10.1155/2014/814524. Epub 2014 Nov 13. PMID: 25477972; PMCID: PMC4247908.
Copy Download .nbib Format: NLM
Share it on

Case Rep Med. 2014;2014:814524. doi: 10.1155/2014/814524. Epub 2014 Nov 13.

Resolution of left ventricular thrombus secondary to tachycardia-induced heart failure with rivaroxaban.

Case reports in medicine

Kosuke Nakasuka, Shigenori Ito, Tsubasa Noda, Takahiro Hasuo, Satoru Sekimoto, Hiroyuki Ohmori, Masahiko Inomata, Takayuki Yoshida, Nozomu Tamai, Tomoaki Saeki, Shin Suzuki, Yoshimasa Murakami, Koichi Sato

Affiliations

  1. Division of Cardiology, Nagoya City East Medical Center, 1-2-23 Wakamizu, Chikusa-ku, Nagoya-shi, Aichi 464-8547, Japan.

PMID: 25477972 PMCID: PMC4247908 DOI: 10.1155/2014/814524

Abstract

A 42-year-old man was admitted to our hospital because of lumbago and tachycardia-induced heart failure. Transthoracic echocardiography revealed impaired left ventricular function and a ball mass of thrombus in the left ventricle (LV). He was found to have systemic embolism in the spleen, kidneys, brain, and limbs. The patient was treated with limb thrombectomy followed by anticoagulation. Seven days after the direct factor Xa inhibitor, rivaroxaban, was initiated, transthoracic echocardiography was repeated, revealing disappearance of the LV thrombus without any clinical signs of cardiogenic embolism. His heart failure responded well and the LV wall motion had improved. This case suggests rivaroxaban has fibrinolytic effects on thrombi even in the LV.

References

  1. Pharmacol Res. 2013 Aug;74:49-55 - PubMed
  2. Int J Cardiovasc Imaging. 2004 Oct;20(5):369-70 - PubMed
  3. J Thromb Thrombolysis. 2012 Nov;34(4):545-7 - PubMed
  4. Australas Med J. 2012;5(3):178-83 - PubMed
  5. Heart Vessels. 2014 Jul;29(4):560-2 - PubMed
  6. Circ Res. 2012 Sep 28;111(8):1069-78 - PubMed
  7. Cerebrovasc Dis. 2013;36(4):322-3 - PubMed
  8. Kardiol Pol. 2011;69(3):294-7 - PubMed
  9. N Engl J Med. 2009 Sep 17;361(12):1139-51 - PubMed
  10. J Am Coll Cardiol. 2011 Mar 15;57(11):e101-98 - PubMed
  11. Thromb Haemost. 2013 Apr;109 (4):583-4 - PubMed
  12. Thromb J. 2013 Dec 20;11(1):26 - PubMed
  13. N Engl J Med. 2011 Sep 15;365(11):981-92 - PubMed
  14. N Engl J Med. 2011 Sep 8;365(10):883-91 - PubMed
  15. Thromb Res. 2013 Mar;131(3):e100-9 - PubMed

Publication Types